Musculoskeletal Imaging

How Should You Image Patients with Osteopenia and Added Vertebral Fracture Risk?

·
How Should You Image Patients with Osteopenia and Added Vertebral Fracture Risk?

A 72-year-old female with a history of rheumatoid arthritis treated with long-term low-dose prednisone presents for a follow-up visit. Her last Dual-energy X-ray Absorptiometry (DXA) scan two years ago showed osteopenia with a lumbar spine T-score of −1.8. Today, she notes her clothes seem to fit differently and a home measurement suggests she has lost about two inches in height. You know she is at high risk for an occult vertebral fracture and accelerated bone loss. The clinical question is clear: what is the most appropriate next imaging step to assess her current bone health and guide management? For this specific scenario, the American College of Radiology (ACR) rates a DXA lumbar spine and hip(s) as Usually appropriate.

Who Fits This Clinical Scenario?

This guidance is for a specific subset of patients who have already been identified as having low bone mass (osteopenia, with a T-score less than −1.0) and possess additional risk factors that significantly increase their near-term risk of a vertebral fracture. The inclusion criteria are precise:

  • A prior DXA showing a T-score less than −1.0, and
  • One or more of the following high-risk features:
    • Advanced age (females ≥ 70 years or males ≥ 80 years)
    • Significant historical height loss (> 4 cm or > 1.5 inches)
    • A self-reported but radiographically unconfirmed prior vertebral fracture
    • Current or recent long-term glucocorticoid therapy (≥ 5 mg prednisone equivalent daily for ≥ 3 months)

This workflow is distinct from other clinical situations. It does not apply to initial osteoporosis screening in an average-risk individual or the routine surveillance of a patient with already-diagnosed osteoporosis (T-score ≤ −2.5). It also differs from the workup for younger, premenopausal women or men under 50, who require a different diagnostic approach. Finally, for patients with advanced degenerative spine disease that could interfere with DXA accuracy, alternative imaging or sites may be prioritized.

What Diagnoses Are You Working Up in This Scenario?

The primary goal of follow-up imaging in this high-risk osteopenic population is to determine if the patient has crossed the threshold into osteoporosis, either by a decline in bone mineral density (BMD) or, more critically, by sustaining a prevalent but clinically silent vertebral fracture. The differential diagnosis guides the imaging choice.

Occult Vertebral Compression Fracture: This is the most consequential diagnosis to identify. Up to two-thirds of vertebral fractures are asymptomatic. The presence of even one moderate vertebral fracture significantly increases the risk of future fractures and changes the patient’s diagnosis to severe osteoporosis, regardless of the T-score. The risk factors in this scenario (advanced age, height loss, steroid use) are potent predictors of these events.

Accelerated Bone Loss Leading to Osteoporosis: The patient may not have a fracture yet, but their underlying condition (e.g., glucocorticoid use) may be causing rapid bone density decline. A follow-up DXA is crucial to quantify this rate of change, which directly informs the urgency and type of pharmacologic intervention needed. The goal is to see if the T-score has now fallen to or below the −2.5 threshold for osteoporosis.

Stable Osteopenia: It is also possible that the patient’s bone density is stable and no fracture has occurred. While reassuring, this result is still clinically valuable. Given their risk factors, these patients still require close monitoring and aggressive management of modifiable risks, but may not need an immediate escalation of therapy.

Why DXA Lumbar Spine and Hip(s) Is the Recommended Study for This Presentation

The ACR designates DXA lumbar spine and hip(s) as Usually appropriate because it is the gold standard for quantitatively measuring bone mineral density and monitoring changes over time. Its precision, low radiation dose, and widespread availability make it the ideal tool for this specific follow-up scenario. The effective radiation dose is minimal (☢ <0.1 mSv), far less than a single chest X-ray.

Crucially, for this patient population, a DXA Vertebral Fracture Assessment (VFA) is also rated as Usually appropriate. VFA is a low-dose lateral spine image acquired on the DXA machine at the same time as the BMD measurement. Its specific purpose is to identify the prevalent vertebral fractures that are a key concern in this scenario. Detecting a fracture via VFA immediately up-stages the patient’s diagnosis to severe osteoporosis and mandates treatment, often bypassing the need for further debate about BMD thresholds.

Alternative studies are rated lower for specific reasons:

  • Quantitative CT (QCT) lumbar spine and hip: While QCT can also measure bone density, the ACR rates it as May be appropriate. Its primary drawback is a substantially higher radiation dose (☢☢☢ 1-10 mSv) compared to DXA, making it less suitable for routine follow-up.
  • Radiography of the axial skeleton: This is also rated as May be appropriate. While excellent for confirming and characterizing a fracture suspected on VFA, standard radiographs cannot provide the quantitative BMD measurement needed to track treatment response or rate of bone loss. They are a supplementary, not a primary, monitoring tool.

If VFA or radiography identifies a vertebral fracture with atypical features, or if there is a concern for underlying malignancy or acute neurologic compromise, further characterization may be necessary. Once you’ve decided on advanced imaging for fracture characterization, our protocol guide covers the technique and reading principles for a potential next step. For example, if there are neurologic signs, an MRI may be indicated: MRI Lumbar Spine Without Contrast.

What’s Next After DXA? Downstream Workflow

The results of the DXA and VFA will guide your next steps in a clear, evidence-based manner. The goal is to translate the imaging findings into a concrete management plan.

If the T-score is now ≤ −2.5 OR a new vertebral fracture is seen on VFA: The diagnosis is now osteoporosis (or severe osteoporosis, if a fracture is present). This finding is a strong indication to initiate or escalate pharmacologic therapy (e.g., bisphosphonates, denosumab, or anabolic agents) to reduce future fracture risk. The presence of a fracture is a particularly powerful motivator for treatment adherence.

If the T-score remains in the osteopenic range (−1.0 to −2.5) AND the VFA is negative for fracture: Calculate the patient’s 10-year fracture risk using a tool like FRAX. For this high-risk cohort, even without a T-score in the osteoporotic range, the combination of risk factors may push their fracture risk above the threshold for initiating pharmacotherapy. If treatment is not started, a repeat DXA is typically scheduled in 1-2 years to continue close surveillance.

If the VFA is indeterminate or suspicious for a fracture: The next step is often to order a dedicated Radiography axial skeleton, which is rated May be appropriate. The superior spatial resolution of a formal radiograph can confirm or refute the presence of a vertebral body deformity and assess its severity (mild, moderate, or severe), which has prognostic implications.

Pitfalls to Avoid (and When to Get Help)

Navigating this scenario requires attention to a few common pitfalls to ensure accurate diagnosis and management.

  • Forgetting to Order VFA: The single most common pitfall is ordering a standard DXA without the VFA component. In this specific high-risk group, screening for an occult vertebral fracture is just as important as measuring the BMD.
  • Over-reliance on Lumbar Spine BMD in Severe Arthritis: Osteophytes and other degenerative changes in the lumbar spine can falsely elevate the measured BMD. In patients with significant spinal arthritis, the hip and distal forearm BMD measurements become more reliable indicators of true bone health.
  • Comparing Scans from Different Facilities: Small but significant differences exist between DXA machines. For the most accurate assessment of change over time, serial scans should be performed on the same machine whenever possible.

If a patient presents with acute, severe back pain, new neurologic symptoms (e.g., radiculopathy, weakness), or a fracture is suspected in the setting of constitutional symptoms like weight loss, escalate immediately for more advanced imaging (radiographs or MRI) and specialist consultation.

Related ACR Topics and Tools

This article focuses on a single, high-risk follow-up scenario. For a comprehensive overview of all clinical variants related to bone density assessment, from initial screening to post-treatment monitoring, please consult our parent guide. You can also use the tools below to explore adjacent scenarios, technical protocols, and radiation dose information.

Frequently Asked Questions

What is a Vertebral Fracture Assessment (VFA) and why is it so important in this scenario?

A VFA is a low-radiation lateral image of the thoracic and lumbar spine performed on the DXA machine. It is critical for this patient group because their risk factors (advanced age, height loss, steroid use) make them highly susceptible to silent vertebral fractures. Finding such a fracture instantly changes the diagnosis to severe osteoporosis and mandates treatment, regardless of the T-score.

Why not just order a standard spine X-ray instead of a DXA with VFA?

While a standard spine radiograph (X-ray) is excellent for visualizing bone anatomy and confirming a fracture, it cannot provide a quantitative measurement of bone mineral density (BMD). A DXA is essential for establishing a baseline BMD and tracking its change over time, which is crucial for assessing the rate of bone loss and the effectiveness of treatment. The VFA provides the fracture screen, while the DXA provides the density measurement, all in one low-dose test.

My patient has severe degenerative arthritis in her lumbar spine. Is a DXA scan still useful?

Yes, but with an important caveat. Severe degenerative changes like osteophytes can falsely elevate the BMD measurement in the lumbar spine, making it seem healthier than it is. In these cases, the BMD measurements at the hip (femoral neck, total hip) and sometimes the distal forearm (1/3 radius) become the most reliable sites for diagnosis and monitoring. The VFA component for fracture detection remains valuable.

How often should follow-up DXA scans be performed for these high-risk patients?

For high-risk patients with osteopenia, especially those on glucocorticoids or with other factors driving rapid bone loss, a follow-up interval of every one to two years is often appropriate. The exact interval depends on the clinical stability, baseline BMD, and whether pharmacologic therapy is being initiated or adjusted.

If a patient reports significant height loss but the VFA is negative for fracture, what should I do?

First, ensure the height loss is accurately measured and documented. If it is confirmed (>4 cm), it remains a major risk factor for future fractures even with a negative VFA. This finding should lower your threshold for initiating pharmacologic therapy based on the patient’s overall fracture risk (e.g., using a FRAX calculation). It also warrants investigation into other potential causes of postural changes or disc space narrowing.

Reviewed by Pouyan Golshani, MD, Interventional Radiologist — May 26, 2026